Nekvnro Acne patch

Manufacturer
Shenzhen Xingqi Technology Co., Ltd.
Effective date
2024-08-08
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 00:16:56

Label at a glance#

ProductNekvnro Acne patch
Active ingredientSALICYLIC ACID, ALOE VERA LEAF
Label structure11 sections

Indications and uses

1: Wipe dry after cleansing, Apply this product to the acne area. 2: The pimple will swell and turn white. 3: Wait for acne to gradually subside 4: Start from the edge and peel it off gently, Then take it down.

Dosage and administration

For external use only.

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 1%

Aloe Vera Leaf Extract 1%

Purpose

OTC - PURPOSE SECTION

Acne patch

Uses

INDICATIONS & USAGE SECTION

1: Wipe dry after cleansing, Apply this product to the acne area.
2: The pimple will swell and turn white.
3: Wait for acne to gradually subside
4: Start from the edge and peel it off gently, Then take it down.

Warnings

WARNINGS SECTION

1,external use,Avoid contact with eyes and mouth.
2,Stop using if you feel irritation or abnormality,Wash with water.
3,Keep this product out of reach of children.

Dosage and administration

DOSAGE & ADMINISTRATION SECTION

For external use only.

Do not use

OTC - DO NOT USE SECTION

1,external use,Avoid contact with eyes and mouth.
2,Stop using if you feel irritation or abnormality,Wash with water.
3,Keep this product out of reach of children.

When using section

OTC - WHEN USING SECTION

1,external use,Avoid contact with eyes and mouth.
2,Stop using if you feel irritation or abnormality,Wash with water.
3,Keep this product out of reach of children.

stop use

OTC - STOP USE SECTION

1,external use,Avoid contact with eyes and mouth.
2,Stop using if you feel irritation or abnormality,Wash with water.
3,Keep this product out of reach of children.

KEEP OUT OF REACH OF CHILDREN SECTION

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep this product out of reach of children.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Hydrocolloid

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labellabel

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
84613-051-012025-07-29C16284748780-13b156c62-3278-fb37-e063-e6dba90a4e071f2bdb90-d3fa-55db-e063-6394a90adf32

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84613-051-01Nekvnro Acne patch30 g in 1 BOXPATCH301

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
84613-051NEKVNRO ACNE PATCH (ACNE PATCH) PATCH [SHENZHEN XINGQI TECHNOLOGY CO., LTD.]11 package rows20240809_1f2bdb90-d3fa-55db-e063-6394a90adf32.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84613-05184613-051-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
1f2bdb90-d3fb-55db-e063-6394a90adf321f2bdb90-d3fa-55db-e063-6394a90adf322024-08-08WarningsExact identifier
spl id: 1f2bdb90-d3fb-55db-e063-6394a90adf32
spl set id: 1f2bdb90-d3fa-55db-e063-6394a90adf32

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.